IKT logo

Inhibikase Therapeutics (IKT) Retained Earnings

Annual Retained Earnings

-$66.90 M
-$19.03 M-39.75%

December 31, 2023


Summary


Performance

IKT Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIKTbalance sheetmetrics:

Quarterly Retained Earnings

-$82.29 M
-$5.78 M-7.55%

September 30, 2024


Summary


Performance

IKT Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIKTbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

IKT Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-39.8%-7.5%
3 y3 years-345.1%-57.2%
5 y5 years-935.5%-57.2%

IKT Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-124.4%at low-176.0%at low
5 y5-year-449.1%at low-575.4%at low
alltimeall time-935.5%at low-575.4%at low

Inhibikase Therapeutics Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$82.29 M(+7.6%)
Jun 2024
-
-$76.51 M(+6.9%)
Mar 2024
-
-$71.55 M(+7.0%)
Dec 2023
-$66.90 M(+39.7%)
-$66.90 M(+6.7%)
Sep 2023
-
-$62.72 M(+7.9%)
Jun 2023
-
-$58.13 M(+11.0%)
Mar 2023
-
-$52.35 M(+9.4%)
Dec 2022
-$47.87 M
-$47.87 M(+9.8%)
Sep 2022
-
-$43.59 M(+11.5%)
Jun 2022
-
-$39.10 M(+13.5%)
DateAnnualQuarterly
Mar 2022
-
-$34.46 M(+15.6%)
Dec 2021
-$29.82 M(+98.4%)
-$29.82 M(+20.3%)
Sep 2021
-
-$24.78 M(+22.0%)
Jun 2021
-
-$20.30 M(+14.9%)
Mar 2021
-
-$17.67 M(+17.5%)
Dec 2020
-$15.03 M(+23.4%)
-$15.03 M(+8.7%)
Sep 2020
-
-$13.82 M(+5.1%)
Jun 2020
-
-$13.15 M(+3.3%)
Mar 2020
-
-$12.73 M(+4.5%)
Dec 2019
-$12.18 M(+88.6%)
-$12.18 M
Dec 2018
-$6.46 M
-

FAQ

  • What is Inhibikase Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Inhibikase Therapeutics?
  • What is Inhibikase Therapeutics annual retained earnings year-on-year change?
  • What is Inhibikase Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Inhibikase Therapeutics?
  • What is Inhibikase Therapeutics quarterly retained earnings year-on-year change?

What is Inhibikase Therapeutics annual retained earnings?

The current annual retained earnings of IKT is -$66.90 M

What is the all time high annual retained earnings for Inhibikase Therapeutics?

Inhibikase Therapeutics all-time high annual retained earnings is -$6.46 M

What is Inhibikase Therapeutics annual retained earnings year-on-year change?

Over the past year, IKT annual retained earnings has changed by -$19.03 M (-39.75%)

What is Inhibikase Therapeutics quarterly retained earnings?

The current quarterly retained earnings of IKT is -$82.29 M

What is the all time high quarterly retained earnings for Inhibikase Therapeutics?

Inhibikase Therapeutics all-time high quarterly retained earnings is -$12.18 M

What is Inhibikase Therapeutics quarterly retained earnings year-on-year change?

Over the past year, IKT quarterly retained earnings has changed by -$5.78 M (-7.55%)